Q301--Reference Laboratory Services - Detroit
Veterans Affairs · 250-NETWORK CONTRACT OFFICE 10 (36C250)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25026Q0126 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
The purpose of this amendment is to provide responses to questions received and provide revised Price Cost Schedule. See attached REVISED Price Cost Schedule - Detroit and Questions with Responses for updated information regarding this requirement. There are no other changes to the terms and condition of this requirement. This amendment does not extend the response date and time. Responses shall be submitted no later than 4:30 PM February 28, 2026 via email to Morgan.Stein@va.gov. Questions with Responses Price Cost Schedule - Can you please clarify the instructions at the top of the spreadshe… (show all)
et?� � "Complete columns B-G" (Column B is filled in with what looks like the current vendor test codes, and column G is the estimated quantity.) RESPONSE: C-G Can proposing vendors add a column at the end of the spreadsheet to include vendor test names for ease of reviewing the proposed test match? RESPONSE: Yes This has been added to the spreadsheet column C now, and the instructions also have been updated For item numbers 2673, 2694, 2401, 2704, 2705, 2706 for Leukemia Lymphoma Phenotyping, please confirm the price to be provided is for a total of markers indicated on the test description, and not a per-marker price? RESPONSE: The pricing that should be provided is for a total of markers indicated on the test panel For item numbers 1248 and 3897, please clarify what type of processing fee? RESPONSE: If there is/are no fee(s) associated with the testing; indicate in the notes and pricing Solicitation document: Quoter shall Provide - "One Copy of turnaround time statement" Please clarify what this requirement is asking for.� Will the turnaround time included in the Price Cost Schedule fulfil this requirement? RESPONSE: The turnaround time listed in the Price/Cost Schedule is helpful; however, quoters must also provide a separate written statement confirming their proposed turnaround time.
Who won similar work
8 award notices on SAM.gov in the last 24 months. Matched by: Same office (250-NETWORK CONTRACT OFFICE 10 (36C250)), same product/service code (PSC) Q301 and NAICS 621511.
Single-winner award sizes (8): middle half $219K to $2.7M, median $331K; range $130K to $4.6M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| LABORATORY CORPORATION | 3 | $10.9M | Aug 31, 2026 |
| CYTOPATH BIOPSY LAB INC | 2 | $533K | Dec 23, 2025 |
| MAYO COLLABORATIVE SERVICES, INC. | 1 | $275K | Apr 20, 2026 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION · $ADPT · $308.1M | 1 | $244K | Dec 30, 2025 |
| VERACYTE LABS SD CORPORATION · $VCYT · $561.9M | 1 | $130K | Nov 19, 2025 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- $ADPT reported $308.1M revenue (12 months to Jun 30, 2026). The median single-winner award in these 8 past awards, $331K, is 0.1% of that. SEC filing
- $VCYT reported $561.9M revenue (12 months to Jun 30, 2026). The median single-winner award in these 8 past awards, $331K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Aug 31, 2026LABORATORY CORPORATION$4.6MQ301--Reference Lab Services - BCVAMC &WCBOCNo listed company matched (Materiality N/A)
- Aug 13, 2026LABORATORY CORPORATION$2.3MQ301--Reference Lab Services - SaginawNo listed company matched (Materiality N/A)
- Apr 20, 2026MAYO COLLABORATIVE SERVICES, INC.$275KEsoteric Lab TestingNo listed company matched (Materiality N/A)
- Dec 30, 2025ADAPTIVE BIOTECHNOLOGIES CORPORATION$244KQ301 - ClonoSEQ Measurable Residual Disease (MRD) Testing ServicesMateriality: 0.08% of $ADPT revenue (Low) SEC
- Dec 23, 2025CYTOPATH BIOPSY LAB INC$146KQ301 - Thyro Seq v3 Genomic Classifier (GC) TestingNo listed company matched (Materiality N/A)
- Nov 19, 2025VERACYTE LABS SD CORPORATION$130KQ301--Decipher Prostate Testing Base- Ann Arbor, Battle Creek and SaginawMateriality: 0.02% of $VCYT revenue (Low) SEC
- Oct 6, 2025CYTOPATH BIOPSY LAB INC$387KQ301--ThyroSeq v3 Genomic Classifier Richard L. Roudebush VA Medical Center Indianapolis, IN 46202No listed company matched (Materiality N/A)
- Jun 30, 2025LABORATORY CORPORATION$4.0MQ301--Indy Reference Laboratory TestingNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 5 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 15 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.